Skip to content

Depression: all studies

Page 549 of 1,034: studies 5,481 to 5,490 of 10,336, newest first. Back to the depression overview

Research

Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice

ACS Pharmacology & Translational Science September 11, 2025 Noelle Cataldo, John A. Razidlo, Cody J. Wenthur 2 citations

Serotonergic psychedelics have shown promise in clinical trials for treating an array of mental health disorders, including depression, anxiety, and post-traumatic stress disorder. Despite these findings, our understanding of how these drugs mechanistically exert their therapeutic effects remains incomplete. While researchers have regularly employed rodent preclinical models to assess such...

Prana Vidya in Integrative Health: Revitalizing Ancient Healing Practices with Modern Scientific Perspectives - A Scoping Review

International Journal of Health Sciences and Research September 10, 2025 Sadhvi Devpriya, Shilpi Verma 1 citation

Background: Prana Vidya, an ancient yogic science rooted in Vedic, Tantric, and Ayurvedic traditions, emphasizes the cultivation, regulation, and application of Prana—the vital life force considered essential for sustaining physiological, psychological, and spiritual health. It represents a subtle energy-based discipline that harmonizes mind–body interactions through breath control, awareness,...

DOI: 10.52403/ijhsr.20250932 (opens in new tab) Meditation Harmony color Alternative medicine Complementary therapy +6

Self-Compassion and Resilience as Mediators of a 30-Day Internet-Delivered Mindfulness-Based Cognitive Therapy: A Pragmatic Open Trial

Research Square September 9, 2025 Paweł Holas, Jan Wardęszkiewicz preprint

Abstract Objectives Emotional distress, encompassing stress, anxiety, and depression, is highly prevalent and associated with substantial personal and societal burden. While Mindfulness-Based Cognitive Therapy (MBCT) is an established intervention, its accessibility is often limited by program length, delivery format, and resource demands. Brief, minimally guided, internet-delivered MBCT...

Enhancing Mindfulness-Based Cognitive Therapy in a Virtual Reality: A Prospective Interventional Study.

Scientific Reports September 9, 2025 Bogoan Kim, Dayoung Jeong, Yoonseon Choi et al.

The increasing prevalence of depression has highlighted Mindfulness-Based Cognitive Therapy (MBCT) as an effective treatment. However, conventional MBCT has several limitations, including barriers to access, the need for trained professionals, and inconsistent levels of participant engagement. The feasibility of using Virtual Reality (VR) for MBCT has emerged as a promising solution, but...

Mindfulness-based Cognitive Therapy (MBCT) Berbasis Kelompok untuk Menurunkan Gejala Depresi pada Remaja

Jurnal Penelitian Pendidikan Psikologi dan Kesehatan September 8, 2025 I Gusti Ayu Agug Prami Yulianarista, Ike Herdiana

Remaja merupakan masa peralihan dari masa anak-anak dan masa dewasa. Depresi pada remaja bukan sekadar perasaan sedih atau stres biasa, melainkan kondisi serius yang permanen dan memengaruhi perilaku, emosi, serta cara berpikir mereka. MBCT dapat melatih remaja mengembangkan metacognitive awareness, yaitu kemampuan untuk mengamati pikiran sebagai peristiwa mental yang sementara, bukan sebagai...

Exploring the importance of bodyset for the psychedelic experience and beyond

Journal of Psychedelic Studies September 8, 2025 Malin Vedøy Uthaug, Giancarlo Allocca, Martha N. Havenith et al. 1 citation

AbstractBackgroundResearch has shown that psychedelics may have therapeutic potential in treating mental disorders like depression and anxiety. However, the mechanisms and actions underlying their effects are still not fully understood. Similarly, while the significance of mindset and setting in shaping psychedelic experiences and therapeutic outcomes is well established, information about the...

The potential of virtual reality for enhancing the efficacy and acceptability of mindfulness training in non-clinical adults: a pilot randomised controlled trial

Virtual Reality September 5, 2025 Marta Modrego-Alarcón, Yolanda López-del-hoyo, María Beltrán-ruiz et al. 3 citations

Abstract Mindfulness-based programmes (MBPs) have proven effective in enhancing mental health outcomes among non-clinical populations, yet they face significant attrition rates. The role of virtual reality (VR) in improving engagement and effectiveness within this context remains uncertain. To explore the potential acceptability and effectiveness of VR-based mindfulness interventions for mental...

Advances in ketamine therapy for multiple psychiatric disorders

Sichuan jingshen weisheng September 5, 2025 Zhang Kai, Cheng Zhaoyang, Wang Yuting

Ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, has gained increasing attention for its rapid antidepressant effects in treatment-resistant depression (TRD) and suicidal ideation. Its mechanisms include NMDA receptor blockade, AMPA receptor activation, and upregulation of BDNF/mTOR signaling. Its enantiomers, esketamine and R-ketamine, as well as its metabolites,...

DOI: 10.11886/scjsws20250531003 (opens in new tab) Full text (opens in new tab) Esketamine Rapid antidepressant Nmda receptor Psychiatric disorders

Psychedelics that Heal and Harm – Their Therapeutic and Recreational Use

Pharmaceutical Science September 4, 2025 Faheema Aziz Wani, Irfan Ahmad Wani

Psychedelic drugs, known for their profound effects on perception, cognition, and emotion, have long captivated scientific, cultural, and therapeutic interest. Following the discovery of LSD’s psychoactive properties in 1943, research surged into its therapeutic potential and the nature of consciousness. However, the integration of psychedelics into the 1960s counterculture led to moral panic,...

Pharmacological Evaluation of Tropane Analogues at the Serotonin Transporter.

ACS Chemical Neuroscience September 3, 2025 Arabo A. Avanes, Hunter T Warren, Abinaya Senthil et al. 2 citations

Tropane alkaloids and their derivatives represent a diverse class of small molecules with a broad range of therapeutic applications. Many tropanes regulate synaptic levels of neuromodulators by interacting with monoamine transporters such as dopamine (DAT) and serotonin (SERT) transporters. While DAT inhibition plays an important role in the addictive potential of tropanes such as cocaine,...